可能的和确诊的杂合子家族性高胆固醇血症患者在表型、基因型及心血管事件方面的差异。
Differences in phenotype, genotype and cardiovascular events between patients with probable and definite heterozygous familial hypercholesterolemia.
作者信息
Cao Ye-Xuan, Zhou Bing-Yang, Sun Di, Li Sha, Guo Yuan-Lin, Zhu Cheng-Gang, Wu Na-Qiong, Gao Ying, Xu Rui-Xia, Liu Geng, Dong Qian, Li Jian-Jun
机构信息
Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, BeiLiShi Road 167, Beijing 100037, China.
Department of Cardiology, Tianjin Chest Hospital, Tianjin Institute of Cardiovascular Diseases, Tianjin 300222, China.
出版信息
Per Med. 2019 Nov;16(6):467-478. doi: 10.2217/pme-2018-0135. Epub 2019 Nov 6.
To investigated the potential differences between probable and definite heterozygous familial hypercholesterolemia (HeFH) patients diagnosed by Dutch Lipid Clinic Network criteria. Clinical characteristics, lipid profile, severity of coronary artery stenosis and gene mutations were compared. Kaplan-Meier curve was performed to evaluate the cardiovascular events. Overall, 325 participants were included and divided into two groups: probable (n = 233) and definite HeFH (n = 92). Definite HeFH patients had higher low-density lipoprotein cholesterol (LDL-C), oxidized-LDL and proprotein convertase subtilisin/kexin 9 levels, and higher prevalence of tendon xanthomas. The incidence of genetic mutations was statistically higher in definite HeFH than probable HeFH patients. The coronary stenosis calculated by Gensini score was statistically severer in definite HeFH patients. The best LDL-C threshold for predicting mutations was 5.14 mmol/l. Definite HeFH had lower event-free survival rates. Definite HeFH patients had higher severity of phenotype and genotype, and higher risk of cardiovascular events.
为研究根据荷兰脂质诊所网络标准诊断的可能的和确诊的杂合子家族性高胆固醇血症(HeFH)患者之间的潜在差异。比较了临床特征、血脂谱、冠状动脉狭窄程度和基因突变情况。采用Kaplan-Meier曲线评估心血管事件。总体而言,共纳入325名参与者,分为两组:可能的HeFH(n = 233)和确诊的HeFH(n = 92)。确诊的HeFH患者具有更高的低密度脂蛋白胆固醇(LDL-C)、氧化LDL和前蛋白转化酶枯草溶菌素/kexin 9水平,以及更高的肌腱黄色瘤患病率。确诊的HeFH患者基因突变发生率在统计学上高于可能的HeFH患者。根据Gensini评分计算的冠状动脉狭窄在确诊的HeFH患者中在统计学上更严重。预测突变的最佳LDL-C阈值为5.14 mmol/l。确诊的HeFH无事件生存率较低。确诊的HeFH患者具有更高的表型和基因型严重程度,以及更高的心血管事件风险。